Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.
Blood Cancer J
; 6(12): e506, 2016 12 09.
Article
in En
| MEDLINE
| ID: mdl-27935580
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoplasms, Second Primary
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2016
Document type:
Article